Leukopenia is a Characteristic Feature of Toxic Shock Syndrome in Children with Burns
Leukopenia is a characteristic feature of toxic shock syndrome (TSS) in children with burns. 1
Clinical Features of Toxic Shock Syndrome in Pediatric Burns
Toxic shock syndrome is a potentially life-threatening condition that can occur in children with burns, even those with minor thermal injuries. Understanding its characteristic features is crucial for early diagnosis and management:
Key Clinical Features
- Leukopenia: A hallmark laboratory finding in TSS, distinguishing it from other infectious complications of burns 1, 2
- Fever: Typically presents within 2-3 days of thermal injury 3, 4
- Erythematous rash: Often diffuse and resembling sunburn 1
- Hypotension: Can progress rapidly to shock 1
- Multiorgan involvement: Including gastrointestinal symptoms (diarrhea, vomiting) 4, 2
- Desquamation: Occurs later in the course of illness 1
Timing and Presentation
- TSS typically develops within 1-7 days after the burn injury (median 2.5 days) 4
- Can occur even with very small burns (as little as 2% total body surface area) 5, 2
- Most commonly affects children under 2 years of age 3
Distinguishing Features from Other Options
Why Leukopenia is Correct
- Leukopenia is a distinctive laboratory finding in TSS that helps differentiate it from other infectious complications of burns 1
- It reflects the superantigen-mediated nature of the disease rather than a typical bacterial infection 1
Why Other Options are Incorrect
- Purulent wound drainage: Not characteristic of TSS; in fact, TSS often occurs with wounds that appear relatively clean 3, 2
- Hypothermia: TSS typically presents with high fever, not hypothermia 1, 4
- Bradycardia: Tachycardia, not bradycardia, is the typical cardiovascular finding in TSS due to the hyperdynamic state and compensatory response to hypotension 1
Management Considerations
Early recognition and prompt management are crucial for improving outcomes:
- Aggressive fluid resuscitation is the cornerstone of initial management 1
- Appropriate antimicrobial therapy should target S. aureus (most common cause in burn-related TSS) 1, 3
- Clindamycin should be included in the regimen to reduce toxin production 6
- Intravenous immunoglobulin may be considered in severe cases to neutralize superantigens 1, 4
- Transfer to a specialized pediatric intensive care unit or burn center may be necessary 3, 2
Important Clinical Pearls
- TSS can occur after discharge from the hospital, highlighting the importance of parent education about warning signs 5
- The cessation of prophylactic antibiotics can sometimes be followed by the development of TSS 5
- Mortality in pediatric TSS (5-10%) is lower than in adults but still significant 1
- Children with comorbidities or immunodeficiencies may be at higher risk for severe presentations 4